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Background
Traumatic brain injury (TBI) is globally a common cause of death especially among the young but due to socio-demographic changes it is also increasing among the frail elderly [1] . The injury progression does not stop at impact [2] but progress over time and harmful secondary events may further deteriorate patients affected [3, 4] . One of these secondary insults is hypoxia at the scene of accident, which may be caused by TBI, obstructive airways or other thoracic trauma, and is present in up to 35% in human TBI patients [5] and has been shown to result in an altered neuroinflammatory response and an unfavorable outcome [6, 7] .
In order to improve diagnostics and management of patients suffering from TBI, protein biomarkers that monitor cerebral pathophysiology have been introduced [8, 9] . While the cerebrospinal fluid (CSF) proteome is in close proximity to the central nervous system [10] , it is difficult to acquire. Moreover, with the discovery of the glymphatic system and the flow of proteins from the central nervous system to blood [11] , it has become more interesting to assess the post-traumatic proteomic spectrum in serum [12] .
The most studied serum protein biomarker is the primarily astrocytic, calcium-binding protein S100 B where levels have been shown to correlate to patient outcome [13] , been useful for monitoring the potential development of secondary injuries [14] and screening for potentially harmful intracranial injury in the emergency room [15] . However S100B is also expressed in other tissues such as fat, skin and bone [16] confounding interpretations of serum levels in patients with more extensive extracranial trauma [17] . Therefore, more brain specific proteins in serum have been suggested to better assess cerebral injury, including Myelin Basic Protein (MBP) [18] , Glial-Fibrillary Acidic Protein (GFAP) [19] and Neuron Specific Enolase (NSE) [20] . Moreover, combinations of proteins may further improve outcome prediction [21] as well as provide a better injury stratification [22] .
While analysis of brain specific proteins currently are being implemented into the clinic to evaluate cerebral injury, the research focus is shifting to the assessment of the underlying pathophysiology in TBI. The inflammatory response has been shown to play an important role [23, 24] with involvement of pro-inflammatory components of the innate immune system, including complement factors and cytokines [25] [26] [27] [28] [29] [30] especially in relation to hypoxic conditions [31] . Studies of serum mediators of inflammation in TBI over a prolonged period of time are limited, since samples commonly are collected only the first hours and day following trauma [32, 33] perhaps missing the complete inflammatory process.
The complex pathophysiological mechanisms that transpire during the different phases of TBI are complicated to monitor in the affected patient. To improve assessment, proteomic analyses of selected proteins have been suggested to provide novel insight into disease pathology [34] [35] [36] [37] . Mass-spectrometry approaches as well as protein arrays for monitoring of different pathophysiological processes in serum following TBI have been used in both pre-clinical and clinical studies [38] [39] [40] . However, many of these have been limited in sample size, and in the case of antibody arrays limited in the number of analyzed proteins.
In our study, we have utilized the extensive resource of antibodies generated within the Human Protein Atlas [41] for analysis of serum proteins in a model of hypoxic TBI in rats up to 28 days following TBI. The primary aim of this study was to compare rats with and without a hypoxic insult. As a secondary aim, the proteins were analyzed by oxygenation state, temporal profile after trauma and how they differed between naïve, sham and TBI animals.
Material and methods

Study sample
The included animals were female Sprague-Dawley (SD) rats, about 15 weeks old weighing 251 g in average. The serum was acquired from rats where the experimental procedure was performed in the scope of a previous study by our group [42] . The rats were kept in 12/12 h dark/light cycle, normal temperature (21 • C) and air humidity. Food and water were provided ad libitum. The Swedish Department of Agriculture approved the ethical permission to perform the study (#N369/12 and #126/13).
Traumatic brain injury model
As previously and thoroughly described, we used a controlled cortical impact (CCI) model that hit exposed dura of a sedated and mechanically ventilated animal [42] . The piston hit the animal in the right parieto-frontal area with a depth of 3 mm, constituting to what is considered a "severe" focal traumatic brain injury [43, 44] . Following impact, the animal was exposed to either normoxic (22% O 2 ) or hypoxic (11% O 2 ) gas mixtures for 30 min as the wound was sutured. The isoflurane was then discontinued, the animal awaken and returned to the home cage after having fully regained consciousness. The injury model, and resulting lesion, is thoroughly described in our previous publication, including a movie of the surgical procedure [42] . In the original experiment, five rats were used per oxygenation group (hypoxia/normoxia) and were sacrificed at day 1, 3, 7, 14 and 28 (n = 50 in total). Moreover, five day 1 and five day 7 normoxia and hypoxia shams were also used (n = 20 in total), as well as three naïve animals (a total of n = 73 rats). The naïve animals had the same sex, age (15 weeks) and weight (average: 248 g) as the experimental and sham animals.
Serum extraction
Shortly following euthanasia, the left ventricle of the heart was punctured using an angiocatheter (18G, KD Medical, Berlin, Germany). Sampling tubes were placed vertically for 60 min to allow separation of coagulation components. After that, the samples were centrifuged (Spectrafuge 16M ® , Labnet International, Edison, USA) for 10 min at 10.000g and the serum stored in −80C • until analysis. Unfortunately, five rats (n = 2 day 7 normoxia, n = 2 day 7 hypoxia and n = 1 day 14 normoxia) did not provide adequate sample volumes and were therefore excluded from the study.
Creation of a targeted antibody suspension bead array
Proteins to be analyzed were selected based on potential association to TBI according to previously published studies (see Supplementary information 1). The proteins represented a variety of functions, including structural damage to cerebral tissue, the inflammatory response, metabolic cascades, cellular signaling, angiogenesis as well as several S100 proteins involved in both cerebral and non-cerebral functions. In total 204 antibodies targeting 143 unique proteins, were selected from the Human Protein Atlas (www.proteinatlas.org) (Fig. 1) . In silico designed protein fragments (PrESTs) of roughly 80-100 amino acids are produced in E.Coli and purified before immunized into rabbits for antibody production. Subsequently, rabbit sera are purified on the respective antigen for antibody purification [45, 46] . Immobilization of antibodies to beads was performed as previously described [47] by activating the magnetic color-coded beads (500 000 beads per identity, MagPlex Luminex Corp.) by using 0.1 M sodium hydrogen phosphate, 0.5 mg of sulfo-NHS (Nordic Biolabs) and 0.5 mg EDC (ProteoChem) per antibody. The activated beads were then incubated for 20 min on a shaker and subsequently washed with MES-buffer. A total concentration of antibody added to the beads was 17.5 ng/l, with each antibody being assigned a specific bead ID. The coupling was allowed to occur for 2 h at ambient temperature. After washing off unbounded protein fragments using 0.1% Tween-20, the beads were blocked using Roche blocking reagent for ELISA (supplemented with 400 l Tween20) overnight and the different bead identities were combined into a suspension bead array.
Serum analysis
Serum samples were processed as previously described [47] . In summary, the samples were randomized in 96-well microtiter plates and diluted 1/10 in PBS prior to labelling. A 10× molar excess of biotin over total protein amount was used for labelling and the reaction was stopped by adding an amount of 250× Tris-HCl over biotin. Before applying samples to the microarray, they were diluted 1/50 in assay buffer PVXcas (0.1% casein (Sigma # c5890500G), 0.5% PVA (polyvinyl alcohol, Sigma # P8136250G), 0.8% PVP (polyvinylpyrrolidone, Sigma # PVP360500G) in 1L PBS) and heat treated at 56 • C for 30 min in a water bath. Following cooling to room temperature for 15 min, 45 l of each sample was combined with 5 l of the bead array solution. The incubation was performed at room temperature overnight.
After washing off unbound proteins with 3 × 100 l PBST (0.05% Tween-20), the interacting proteins were cross-linked for 10 min using 0.4% paraformaldehyde. A second wash was followed by addition of detection reagent (streptavidin conjugated R-phycoerythrin, Invitrogen, 1:750 diluted in PBST) and incubation was performed for 30 min. Finally, the interacting proteins were analysed using a FlexMap3D instrument (Luminex Corp.) and the relative proteins abundances reported as median fluorescent intensity (MFI) per sample and bead ID. The estimated detection limit in the current sample environment has been shown to be in the low ng/mL to high pg/mL range [48] , as is common in single-binder assays [49] .
Statistical analysis
Relative protein abundances from the suspension bead array analysis were reported as median fluorescence intensity (MFI) for each sample and antibody. We repeated the identical assay twice, inter-assay correlation for all antibodies were calculated using Spearman and Pearson correlations. In order to be considered a significant result and to reduce the risk of false positive findings, the detected protein needed to be increased in both assays with either a p-value < 0.05 in both, or presenting a strong trend towards significance in one and p < 0.05 in the other. To simplify, the visualized results shown are all from assay 2. Linear models (made using the package "ggplot2" [50] ), boxplots and volcano plots for data visualization and analysis were made in the statistical program R [51] . For the different survival times after trauma, 1 and 3 days were considered "Early" while 14 and 28 days were defined as "Late". Statistical significance for differences between groups was calculated using Wilcoxon rank sum test. Early vs late survival times, hypoxia vs normoxia, experimental vs sham surgery as well as experimental vs naïve animals were also compared. Principal component analysis (PCA) was performed using R ("princomp") on the proteins that showed significant features in the different comparisons, to explore potential protein-interactions. Only protein concentrations from experimental animals (not sham and naïve) were included in the PCA analysis. PCA determines "principal components" (PCs) which are linear combinations of all the variables in the model. PCA is useful when assessing complex datasets with multiple variables, especially with relatively small numbers of observations [52] . Both a loading plot, highlighting potential co-variance among the proteins of interest in this study in the two first PCs, and a scores plot, which visualizes how the different component scores per animal contributed, were used. This method is similar to what has previously been used to study a panel of cytokines in TBI patients [53] as well as a method to visualize effect of neuroinflammatory treatment in TBI [54] .
Results
We analyzed a total of 68 rat serum samples in two identical assays containing 204 antibodies targeting 143 unique proteins. The relative protein levels were compared over different survival times, injured versus uninjured animals and oxygenation state. Overall, a high intra-individual correlation between the two assay runs could be observed for the proteins that were significant in the different analyses (Supplementary Fig. 1 ).
Differences in protein levels over time after trauma
The protein profile of serum collected 1 and 3 days (n = 20) vs 14 and 28 days (n = 19) after trauma were analysed and compared in two repeated assays ( Supplementary Fig. 2 , Volcano Plot). Complement factor 9 (C9) ( Fig. 2A, line graph) (Fig. 3, boxplot) and Complement factor B (CFB) (Fig. 3) , proteins involved in the primary innate complement system, were found increased early after injury and then decreased ( Table 1) . Aldolase c (ALDOC) (Fig. 3) , also decreased significantly over the 28 days. In contrast, the signaling protein HIF1␣ had a different temporal trajectory, with an increasing trend in the 4 weeks following TBI. An increasing temporal pattern was also seen for the previously relatively unstudied protein Williams-Beuren syndrome chromosome region 17 (WBSCR17) (Fig. 2B) (Fig. 3) . Moreover, amyloid precursor protein (APP) increased in serum after injury (Fig. 3 ).
Differences between injured animals and naïves
Spectrin 1 ␣ (SPTAN) was significantly increased in normoxic shams vs experimental normoxic animals ( Table 1 ). Other proteins that exhibited significant differences between normoxic shams compared to experimental normoxic animals in both assay runs are illustrated in Table 1 . In hypoxic shams vs hypoxic experimental animals, no proteins exhibited significant differences. All concentrations for shams vs experimental animals on day 1 for hypoxic and normoxic animals are presented in Supplementary Fig. 3A -B.
For naïve animals, C9 and CFB levels were higher in the experimental animals compared to the naïve, i.e similar proteins that significantly decreased over time in the injured animals ( Table 1) . There were no significant protein differences in serum between naïve animals and experimental animals day 28 (data not shown).
Protein profile differences between normoxic and hypoxic animals
Concerning protein profile differences between the two different oxygenation states (n = 22 normoxia vs n = 24 hypoxia) ( Supplementary Fig. 4 ), the protein S100A9 (Fig. 2C ) levels were higher in the hypoxic animals ( Table 1 ). In order to find proteins that might have been increased more early after injury, we compared animals at day 1 and 3 hypoxia vs normoxia but did not find any significant differences (data not shown).
Principal component analysis of the highlighted proteins
The two first principal components from the PCA performed on the proteins in Table 1 had an aggregated explained variance of 0.61 (PC1 = 0.31, PC2 = 0.30). As can be seen in the Loading plot (Fig. 4A) , where the loadings of the different proteins of interest in the analyses are plotted, some proteins are highly correlated, including C9 and CFB, thus they provide limited independent information if used together. Further, PC1 seems to represent the temporal profile with early high proteins with a negative PC1 (C9, CFB, ALDOC) and proteins that increased over time (HIF1A, APP, WBSCR17) had a positive PC1. This is also visualized in the Scores plot which plots For analysis of serum profiles, 204 antibodies were chosen, targeting 143 unique proteins. The Sprague-Dawley rats underwent a controlled cortical impact (focal traumatic brain injury) or sham surgery, and were exposed to normoxic or hypoxic conditions. Serum samples were acquired from animals when sacrificed at 1, 3, 7, 14 and 28 days following trauma. Protein profiling was performed and comparisons made between survival times, oxygenation states and experimental vs non-experimental animals, visualized using different plots and graphs. The trend and p-value from the two assays for proteins with significant differences in the various analyses performed. Fold change and median fluorescence intensity (MFI) differences (median, interquartile range) for assay 2 are also presented.
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every animal (Fig. 4B) , where animals with a negative PC1 have shorter survival times compared to animals with longer survival times. Hypoxia did not have any obvious effect on the two first PCs for the chosen proteins.
Discussion
In this study we utilized an antibody suspension bead array setup to analyze protein profiles in serum from rats suffering from experimental TBI. There was an increase in proteins in the complement system as well as for ALDOC immediately after trauma that later on decreased the following weeks. The same proteins were also significantly increased compared to naïve animals. HIF1␣, together with WBSCR17 and APP, were low after injury but increased as time progressed. The added hypoxic insult resulted in a general increase of protein levels in serum, albeit few reaching statistical significance, except for S100A9. The PCA revealed a spread in variance between the analyzed proteins, clustering complement proteins together with ALDOC on one side of the PC1 while HIF1A, WBSCR17 and APP were positioned on the other side of the spectrum, highlighting which proteins that have a great co-variance in the dataset. Fig. 4A illustrates a loading plot which shows how the contribution of the proteins to the first two components. The size of the dot represents an increasing Euclidian distance from the origin, thus giving proteins that were more explained by the two first PCs larger dots. Fig. 4B is a scores plot where the dots represent the different experimental animals and how their corresponding serum protein profile is represented in the two first principal components. Survival time (in days) was plotted as increasingly warm red colors.
The complement system is a vital part of the innate immune response, involved in chemotaxis and opsonization of injured cells following TBI [55, 56] . One of the most important steps in the complement cascade is factor C5b-9, forming the membrane attack complex involved in the lysis of cells [57] . C5b-9 has been shown to play a role in the secondary cell death following TBI [58, 59] and elevated levels have been seen in serum early after injury [60] . While a C5b-9 antibody was not available from the HPA at the time of analysis, complement factor B and complement component 9, which constitute the membrane attack complex, were, and they showed similar results with increased levels in serum early after trauma that decreased over time. We believe that our findings indicate an up-regulation of the innate immune response early after TBI, as has been suggested by other groups [55, 56] . Moreover, inhibition of several complement proteins, including C5b-9 [61] and complement factor B [62] , have been shown to improve outcome following brain injury. These complement proteins were also upregulated in experimental compared to naïve animals, indicating their potential value as an injury markers. However, the two complement proteins differed little in explained variance, as highlighted by the PCA, thus indicating that it is probably sufficient to measure one of these proteins to retain information about the complement cascade activity. In addition, the protein concentration in serum of complement proteins exhibited similar temporal dynamics as was seen in immunohistochemistry sections of C5b-9 for corresponding animals in our previous study [42] . All in all, complement proteins were increased early after injury with a subsequent decline the following weeks, presumably as markers for increased innate immunity.
The protein ALDOC, involved in hypoxic regulation and signaling, significantly decreased over time in serum from injured animals. While previous studies of serum levels in TBI are lacking, the ALDOC gene has been shown to be both up- [63] and down-regulated following stroke [64] , where the latter study saw a decrease of the protein in the affected brain, supposedly as a response to a metabolic down-regulation. Thus, decreasing levels in serum of ALDOC might be indicative of the similar temporal trend seen in the brain following injury.
In the injured brain, HIF1A expression has been shown to increase over time [65] [66] [67] and serum levels remain elevated for at least one month [38] , similar to the increasing trajectory that was seen in our study. As a transcription factor increased by tissue suffering from inadequate oxygen delivery, the delayed increase of HIF1A in serum could be due to its association to ongoing apoptosis in the injured brain [65] . However, increasing HIF1A expression could also be an indicator for neuro-protection and tissue regeneration in the injured brain [68, 69] . In contrast, this temporal trend was the opposite of what was found in brain sections for HIF1A, where the concentration decreased over time after injury [42] . The secretion of the protein from brain to serum is not fully understood, and would presumably exhibit a different effect than if synthetized in affected tissue. Currently, no clear consensus exists of systemic activity of HIF1A even if circulating levels have been suggested as markers for conditions such as diabetes and cancer [70, 71] . APP, a protein accumulated in patients suffering from Alzheimer's disease, where CSF levels act as a biomarker of disease severity [72] , is not thoroughly investigated in serum following TBI. Nevertheless, the reported findings suggest an increase in serum over time following TBI with higher levels in more severe injuries [73] , presumably indicating similarities between the aftermath of TBI and neurodegeneration. The protein WBSCR17, known for being deleted in patients suffering from the congenital Williams-Beuren syndrome (WBS) (leading to several symptoms, among others abnormalities in the parietal-dorsal areas of the neocortex) was included in the study because of its cerebral specificity according to gene expression data available in the Human Protein Atlas, and increased in serum after injury. A previous in vitro screening study indicated that the WBSCR17 gene was down-regulated immediately following chemical injury to the CNS [74] , but to our knowledge, no long-term in vivo studies of the protein in a traumatic setting have been reported. Speculatively, the increase of WBSCR17 in serum might highlight a release of a brain enriched protein from the injured cortex. The PCA revealed that the proteins exhibited similar variance, albeit not as obvious as for the complement proteins, something that might indicate different properties or a different origin of these proteins. Altogether, HIF1A, APP and WBSCR17 increased over time after injury, presumably highlighting different aspects of the disease process following TBI.
Interestingly, spectrin levels in serum (SPTAN1) were significantly increased in both sham groups if compared to the TBI animals. Spectrin is a cytoskeleton protein playing an important role in the plasma membrane integrity and increased levels of spectrin brake down products have been shown to correlate to an unfavorable outcome following TBI [75, 76] . A similar pattern seen in our study was detected by Boutté and co-workers where they saw that animals with penetrating brain injuries had significantly lower cerebral levels of spectrin compared to corresponding shams [77] . They suggested that the acute down-regulation of SPTAN in cerebral tissue may be due to degradation, and that later increases (normalization of SPTAN levels) were due to attempts of spontaneous repair and recovery could be related to neuronal survival in the injured brain [78, 79] . Moreover, the discrepancy with some other studies that saw increased levels of similar proteins in serum after injury could be due to different proteins targeted and antibodies used, as the brake-down products of spectrin (more commonly studied in TBI) are currently not available in the Human Protein Atlas.
Hypoxia resulted in generally increased levels of serum proteins, although no reached statistical significance in both assay runs. Since a majority of our analysed proteins were brain specific (according to tissue specific lists provided by the Human Protein Atlas [80] ), this could in theory indicate greater cerebral tissue damage in the hypoxic animals. The result is however similar to our previous study where we only detected an increasing trend of S100B 24 h after trauma in the hypoxic animals, while no other time point showed any differences [42] . S100A9, that was found with increasing trends in hypoxic animals, has previously been shown to promote leukocyte, primarily neutrophil, adhesion and migration from blood vessels [81] , to be important in neurodegeneration and up-regulated in conditions such as Alzheimer's disease [82] . S100A8 and S100A9 together form a stable dimer, S100A8/A9 (Calprotectin), which has potent pro-inflammatory properties [81] and could be a reason why S100A9 was increased in the more severely injured hypoxic rat. In general, there was no obvious trend for oxygenation state in the PCA, indicating that for the chosen proteins in serum, only limited variance was explained by the presence of hypoxic or normoxic conditions following TBI.
In this study, we used survival and sampling times spread out over 28 days which revealed interesting trends in several protein concentrations. However, if earlier time-points would have been chosen, hours after trauma instead of day (s), the results might have been different [83] . This is probably one reason why other serum proteins such as S100B, NSE, GFAP, MBP and Neurofilaments, did not present differences between hypoxic and normoxic animals, or over time, in the current study. Further, in an exploratory approach, we did look at only days 1 and 3 (normoxia vs hypoxia) which showed a similar trend as if all animals were analyzed and compared (even though the sample sizes were a lot smaller). However, this is similar to our recent study were the same animals were used and we noticed a significant increase in serum only in day 1 animals compared to the n = 3 naïve for S100B, using a commercially available ELISA [42] . Several of the putative protein markers of injury have seen to normalize in serum even 24 h -3 days after injury [7, 84, 85] . Had earlier time-points been used, perhaps we would have noticed greater differences both between naïve and injured animals, as well as normoxic and hypoxic animals. We also acknowledge the unknown but likely different antibody affinity, in the current study for rodent epitopes versus commercially available assay kits, even if several antibodies show good affinity to mouse brain tissue [86] .
In summary, for future analyses, we propose that earlier survival times, different assay kits and potentially even more severe secondary injuries should be added order to reveal a difference between proteins suggested as markers of tissue fate.
The number of sham and naïve rats was fewer than the experimental rats, resulting in comparison difficulties between the groups. However, aside from SPTAN, the complement proteins were the only proteins significantly decreased in the naïve rats if compared to both hypoxic and normoxic animals. Several proteins remained unaltered between the sham and trauma animals. The sham surgery is invasive as it includes a craniectomy which may release several of these proteins that are increased in the injured animals as well, as we noticed with the sham animals and S100B in our previous study [42] . Moreover, in the day 7 sham animals, the animals have been living with an exposed dura for a week which might cause distress on the underlying parenchyma and thus influence results as a potential source of protein release in serum. This is similar results as in the extensive Operation Brain Trauma Therapy where it was shown that the sham surgery perform released similar amount of biomarkers as for the experimental animals [87] . It should also be mentioned that while several genes have been shown to both up-or downregulate in response to TBI [88] , and while these are often studied in brain parenchyma, screening of the serum proteome have never previously been done in this fashion making it difficult to assess if an increase or decrease in serum of a specific protein is detrimental or beneficial. Plus, for a protein to function as a viable biomarker in serum, it is of interest to analyze its clearance, half-life and shift between different compartments (extracellular cellular brain fluid to cerebrospinal fluid and to blood) in the TBI setting, something that will be essential for future research to fully evaluate proteins for potential use as biomarkers. We also stress that other assays and future profiling of the serum proteome is necessary to confirm our current findings.
However, we do believe that our findings suggest that a panel consisting of multiple proteins could be better used to monitor the complex underlying pathophysiology following conditions such as TBI.
Limitations
Like previously mentioned, this study focuses on comparisons with late time points which might be less clinically relevant in the acute setting. Several proteins have been shown to normalize as early as 24 h after injury [24, 84] , so for some of the chosen proteins we probably missed the critical time frame. Nevertheless, we present a well monitored cohort for a longer period than previously described which resulted in other important findings.
In general, the sample sizes were small, particularly the number of naïve rats, which is something that limits the specific comparison between uninjured and experimental animals. However, the current choice of n = 5 animals per group is not uncommon in similar studies to detect a valid effect size [38, 89] . Furthermore, for the naïve animals, we aimed for a large effect size in protein differences, and exclusively highlight the proteins that do present differences even in a small sample size.
While the rats suffered from 30 min hypoxia following a focal brain injury [42] , this did not significantly influence the serum levels of a number of proteins in the current study. In the previous study using the same animals, the hypoxic insult resulted in an increased neuronal death even though the protein expressions in CNS were decreased compared to normoxic rats [42] . Perhaps more severe hypoxia, in combination of a systemic hemorrhage, would result in a more severe secondary insult and subsequently alter the serum biomarker profile to a greater extent.
Conclusions
A general increase of complement proteins and ALDOC was detected early after injury, while the levels of APP, HIF1A and WBSCR17 increased following 14-28 days after injury. An added hypoxic insult resulted in an increase of a majority of the proteins in serum, albeit few reached statistical significance. More extensive research of the serum proteome following TBI is necessary to further validate our findings.
